Company Search:
Advanced Search
Sponsored Links
Obi Pharma Inc Company Snapshot
Obi Pharma Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Obi Pharma Inc with three other companies in this sector in TAIWAN : Pharmigene Inc (2020 sales of 101.35 million Taiwanese Dollars [US$3.64 million] ), Phytohealth Corp (91.81 million Taiwanese Dollars [US$3.30 million] of which 40% was Medical Appliance), and Taiwan Liposome Co Limited (101.93 million Taiwanese Dollars [US$3.66 million] of which 56% was Authorized cooperative development incom).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Obi Pharma Inc
  Stock Performance Chart for Obi Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 104.00
(Figures in Taiwanese Dollars )
1 Week -3.3%   13 Weeks 10.9%  
4 Weeks -12.2%   52 Weeks -10.3%  
Obi Pharma Inc Key Data:
  Ticker: 4174 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 140,886,000
(Year Ending Jan 2021).
Employees: 82
  Currency: Taiwanese Dollars Market Cap: 20,690,633,600
  Fiscal Yr Ends: December Shares Outstanding: 198,948,400
  Share Type: Ordinary Closely Held Shares: 69,580,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.